Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELLDOPA
NCT00004733Phase 3Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Jan 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levodopa in Parkinson's disease (PD), sponsored by National Institute of Neurological Disorders and Stroke. Started Jan 1998; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00004733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004733.